AG
EW icon

AIA Group’s Edwards Lifesciences EW Stock Holding History

AIA Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Buy
212,805
+75,762
+55% +$6.35M 0.24% 59
2026
Q1 		$11M Buy
137,043
+10,083
+8% +$831K 0.16% 93
2025
Q4 		$10.8M Sell
126,960
-181,265
-59% -$14.9M 0.16% 86
2025
Q3 		$24M Sell
308,225
-314,688
-51% -$24.6M 0.42% 34
2025
Q2 		$48.7M Sell
622,913
-42,665
-6% -$3.18M 1.06% 16
2025
Q1 		$48.2M Sell
665,578
-265,355
-29% -$19M 1.18% 14
2024
Q4 		$68.9M Buy
930,933
+181,409
+24% +$12.7M 1.66% 9
2024
Q3 		$49.5M Buy
749,524
+358,556
+92% +$26.1M 1.28% 17
2024
Q2 		$36.1M Sell
390,968
-102,001
-21% -$9.03M 1.06% 23
2024
Q1 		$47.1M Sell
492,969
-108,776
-18% -$9.14M 1.54% 12
2023
Q4 		$45.9M Buy
601,745
+134,452
+29% +$9.36M 1.88% 10
2023
Q3 		$32.4M Buy
467,293
+76,319
+20% +$6.13M 1.58% 15
2023
Q2 		$36.9M Sell
390,974
-72,237
-16% -$6.28M 1.79% 12
2023
Q1 		$38.3M Buy
463,211
+228,272
+97% +$17.9M 2.08% 12
2022
Q4 		$17.5M Buy
234,939
+25,131
+12% +$1.94M 1.07% 19
2022
Q3 		$17.3M Buy
209,808
+196,330
+1,457% +$18.9M 1.14% 20
2022
Q2 		$1.28M Sell
13,478
-3,810
-22% -$394K 0.07% 124
2022
Q1 		$2.04M Sell
17,288
-1,854
-10% -$208K 0.09% 108
2021
Q4 		$2.48M Buy
19,142
+14,582
+320% +$1.7M 0.12% 85
2021
Q3 		$516K Buy
4,560
+762
+20% +$87K 0.03% 166
2021
Q2 		$391K Buy
+3,798
New +$358K 0.03% 158

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

AIA Group's EW Position: Q2 2026 in Review

AIA Group increased its Edwards Lifesciences (EW) stake by 55% in Q2 2026, buying an estimated $6.35M and bringing the position to 212,805 shares worth $19.3M. The position accounts for 0.24% of the portfolio, ranked #59.

AIA Group first reported a position in EW in Q2 2021 and has held it in 21 quarters since. The position peaked at $68.9M in Q4 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • AIA Group held 212,805 shares of Edwards Lifesciences worth $19.3M as of Q2 2026.
  • AIA Group bought 75,762 Edwards Lifesciences shares in Q2 2026, an estimated $6.35M.
  • Edwards Lifesciences made up 0.24% of AIA Group's portfolio in Q2 2026, its #59 holding.
  • AIA Group first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • AIA Group's Edwards Lifesciences position peaked at $68.9M in Q4 2024.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.